Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion

Nephrology Dialysis Transplantation

Volumn 13, Issue 9, 1998, Pages 2227-2233

  Higueruelo, Sonia ^a   Vaquero, Manuel ^a   Pastor, Cruz ^a   Galimany, Roman ^a   Romero, Ramon ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotesin II; Eicosanoid secretion; Incipient glomerular lesion; Macrophage ED1 cells; Nephropathy; Xanthomatous cells

Indexed keywords

ANGIOTENSIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; ICOSANOID; LIPID; PROSTAGLANDIN; PROSTAGLANDIN E2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLOMERULOPATHY; HYPERCHOLESTEROLEMIA; KIDNEY DISEASE; LIPID BLOOD LEVEL; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEINURIA; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHOLESTEROL; CHOLESTEROL, DIETARY; EICOSANOIDS; FOSINOPRIL; KIDNEY GLOMERULUS; OBESITY; PROTEINURIA; RATS; RATS, ZUCKER;

EID: 0031687577     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.9.2227     Document Type: Article

References (43)

1. Walker WG. Relation of lipid abnormalitics to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus. Miner Electrolyte Metab 1993; 19: 137-143
2. Shohat J, Boner G. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis. Isr J Med Sci 1993; 29: 228-239
3. Mulec H, Johnson S-A, Björck S. Relation between serum cholesterol and diabetic nephropathy. Lancet 1990; 335: 1537 1538
4. Ekberg G, Grefberg N, Larsson O, Vaara I. Relation between serum cholesterol and diabetic nephropathy. Lancet 1990; 330: 954
5. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistcnce, hyperlipidemia and renal injury. Hypertension 1992; 19: 1110-1115
6. Kasiske BL, O'Donncll MP, Clearly MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667-672
7. Kasiske BL, O'Donnell MP, Gravis WJ, Keane WF. Pharmacological treamcnt of hyperlipidemia reduces glomerular injury in 5/6 nephrectomy model of chronic renal failure. Cire Res 1988; 62: 367-374
8. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF. Renal injury of diet-induced hypercholesterolaemia in rats. Kidney Int 1990; 37: 880 891
9. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307: 652
10. Halunska PV, Lurie D, Colwell JA. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med 1977; 297: 1306 1310
11. Colwell JA, Halushka PV, Sarji KE, Sagel J. Platelet function in diabetes mellitus. Med Clin N Am 1978; 62: 753-766
12. Guijarro C, Kasiske BL, Kim Y. O'Donnell MP, Lee HS, Keane WF. Early glomerular changes in rats with dietary-induced hypercholesterolaemia. Am J Kidney Dis 1995; 26: 152-161
13. Sassy-Prigent C, Heudes D, Jouquey S et al. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition. Lab Invest 1995; 73: 64-71
14. Lavaud S, Michel O, Sassy-Prigent C et al. Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 1996; 7: 2604-2615
15. Berstein E, Shai S-Y, Howard T, Balogh K, Frenzal K, Langford K. Structure and regulated expression of angiotensin-converting enzyme and the receptor for angiotensin II. Am J Kidney Dis 1993; 21: 53-57
16. Nakamura T, Takahashi T, Fukui M et al. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 1995; 5: 1492-1497
17. Ruiz-Ortega M, Gomez-Game D, Alcazar R et al. Involvement of angiotensin II and endothelin in matrix production and renal sclerosis. J Hypertension 1994; 12: S51-S58
18. Keilani T, Schlueter WA, Levin ML, Batlle DC. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med 1993; 118: 246-254
19. Ravic M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney Int 1995; 47: 907-910
20. Mulec Henrik, Johnsen SA, Wiklund O, Björck S. Cholesterol. A renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22: 196-201
21. Higueruelo S, Romero R. Comparative effects of pravastatininduced DNA synthesis on serum-stimulated synchronized and proliferative rat mesangial cells. Pharmacol Res 1996; 34: 117-120
22. Krolewski AS, Warram JH. Christlieb AR. Hypercholesterolaeima-a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994; 45: S125 S131
23. Gröne HG, Wali A, Gröne E et al. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab Invest 1989; 60: 443-446
24. Al-Shebeb T, Frohlich J, Magil A. Glomerular disease in hypercholesterolaemic guinea pigs: a pathogenic study. Kidney Int 1988; 33: 498-507
25. Diamond JR, Karnovsky MJ. Aggravating effects of hyperlipidemia on macrophage function in nephrosis (abstract). Kidney Int 1989; 35: 426
26. Hattori M, Yamaguchi Y, Kawaguchi H, Ito K. Characteristic glomerular lesions in ExHC rat: a unique model for lipid-induced glomerular injury. Nephron 1993; 63: 314-322
27. Holdsworth SR, Neale TJ, Wilson C. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest 1981, 68: 686-691
28. Magil AB, Frohlich JJ. Monocytes and macrophages in focal glomerulosclcrosis in Zucker rats. Nephron 1991; 59: 131-138
29. Shlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 1993; 15: 443-450
30. Diamond JR, Pesek I, McCarter MD, Karnovsky MJ. Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolaemia. Am J Pathol 1989; 135: 711-718
31. Perilo N, Benigni A, Gabanelli M et al. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperfunction of diabetic rats. Diabetes 1992; 41: 533-538
32. Shamberland M, Blake S. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1985; 75: 404-412
33. Neumayer H-H, Heinrich M, Schmissas M, Haller H, Wagner K, Luft FC. Amelioration of ischemic acute renal failure by dietary fish oil administration in conscious dogs. J Am Soc Nephrol 1992; 3: 1312-1320
34. Craven PA, Melhem MF, De Rubertis FR. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int 1992; 42: 937-946
35. Baylis C, Brenner BM. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res 1978; 43: 889-898
36. Savage S, Schrier RW. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors. Adv Intern Med 1991; 37: 85-101
37. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
38. O'Donnell MP, Kasiske BL, Shmidtz PG, Katz SA, Keane WF. Enalapril reduces glomerular injury in obese Zucker rats (abstract). Kidney Int 1989; 35: 434
39. Sakemi T, Baba N. Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats. Nephron 1993; 63: 323-329
40. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85: 541-549
41. Keane WF, Shapiro BE. Renal protective effect of angiotensin-converting enzyme inhibitors. Am J Cardiol 1990; 65: 491-531
42. Brunner HR. ACE inhibitors in renal disease. Kidney Int 1992; 42: 463-479
43. Zatz R, Dunn BR, Meycr TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925 1930